Evidence for the influence of the iron regulatory MHC class I molecule HFE on tumor progression in experimental models and clinical populations

Cody Weston, James Connor

Research output: Contribution to journalReview article

4 Scopus citations

Abstract

Proteins involved in iron regulation are modifiers of cancer risk and progression. Of these, the HFE protein (high iron gene and its protein product) is of particular interest because of its interaction with both iron handling and immune function and the high rate of genetic polymorphisms resulting in a mutant protein. Clinical studies suggest that HFE polymorphisms increase the risk of certain cancers, but the inconsistent outcomes suggest a more nuanced effect, possibly interacting with other genetic or environmental factors. Some basic science research has been conducted to begin to understand the implications of variant HFE genotype on cancer, but the story is far from complete. In particular, putative mechanisms exist for HFE to affect tumor progression through its role in iron handling and its major histocompatibility complex class I structural features. In this review, the current understanding of the role of HFE in cancer is described and models for future directions are identified.

Original languageEnglish (US)
JournalTranslational Oncogenomics
Volume6
DOIs
Publication statusPublished - Dec 4 2014

    Fingerprint

All Science Journal Classification (ASJC) codes

  • Oncology
  • Genetics
  • Cancer Research

Cite this